3wf0: Difference between revisions

<table><tr><td colspan='2'>[[3wf0]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3WF0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3WF0 FirstGlance]. <br>

</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>

<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6DJ:(3Z,6S,7R,8S,8AS)-3-(BUTYLIMINO)HEXAHYDRO[1,3]THIAZOLO[3,4-A]PYRIDINE-6,7,8-TRIOL'>6DJ</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>

[https://www.uniprot.org/uniprot/BGAL_HUMAN BGAL_HUMAN] GM1 gangliosidosis type 2;Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 1;GM1 gangliosidosis type 3. GM1-gangliosidosis 1 (GM1G1) [MIM:[https://omim.org/entry/230500 230500]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM1 gangliosides, glycoproteins and keratan sulfate primarily in neurons of the central nervous system. GM1-gangliosidosis type 1 is characterized by onset within the first three months of life, central nervous system degeneration, coarse facial features, hepatosplenomegaly, skeletal dysmorphology reminiscent of Hurler syndrome, and rapidly progressive psychomotor deterioration. Urinary oligosaccharide levels are high. It leads to death usually between the first and second year of life. Note=The disease is caused by mutations affecting the gene represented in this entry.<ref>PMID:1928092</ref> <ref>PMID:1909089</ref> <ref>PMID:1907800</ref> <ref>PMID:1487238</ref> <ref>PMID:8213816</ref> <ref>PMID:11511921</ref> <ref>PMID:12393180</ref> <ref>PMID:10338095</ref> <ref>PMID:10839995</ref> <ref>PMID:10737981</ref> <ref>PMID:15365997</ref> <ref>PMID:15714521</ref> <ref>PMID:15791924</ref> <ref>PMID:16941474</ref> <ref>PMID:16538002</ref> <ref>PMID:17309651</ref> <ref>PMID:19472408</ref>  GM1-gangliosidosis 2 (GM1G2) [MIM:[https://omim.org/entry/230600 230600]: A gangliosidosis characterized by onset between ages 1 and 5. The main symptom is locomotor ataxia, ultimately leading to a state of decerebration with epileptic seizures. Patients do not display the skeletal changes associated with the infantile form, but they nonetheless excrete elevated amounts of beta-linked galactose-terminal oligosaccharides. Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.<ref>PMID:1909089</ref> <ref>PMID:1907800</ref> <ref>PMID:8213816</ref> <ref>PMID:10737981</ref> <ref>PMID:15714521</ref> <ref>PMID:16941474</ref> <ref>PMID:17309651</ref> <ref>PMID:19472408</ref> <ref>PMID:12644936</ref>  GM1-gangliosidosis 3 (GM1G3) [MIM:[https://omim.org/entry/230650 230650]: A gangliosidosis with a variable phenotype. Patients show mild skeletal abnormalities, dysarthria, gait disturbance, dystonia and visual impairment. Visceromegaly is absent. Intellectual deficit can initially be mild or absent but progresses over time. Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.<ref>PMID:1909089</ref> <ref>PMID:1907800</ref> <ref>PMID:11511921</ref> <ref>PMID:16941474</ref> <ref>PMID:17309651</ref> <ref>PMID:19472408</ref> <ref>PMID:8198123</ref> <ref>PMID:7586649</ref> <ref>PMID:11511921</ref> <ref>PMID:15986423</ref>  Mucopolysaccharidosis 4B (MPS4B) [MIM:[https://omim.org/entry/253010 253010]: A form of mucopolysaccharidosis type 4, an autosomal recessive lysosomal storage disease characterized by intracellular accumulation of keratan sulfate and chondroitin-6-sulfate. Key clinical features include short stature, skeletal dysplasia, dental anomalies, and corneal clouding. Intelligence is normal and there is no direct central nervous system involvement, although the skeletal changes may result in neurologic complications. There is variable severity, but patients with the severe phenotype usually do not survive past the second or third decade of life. Note=The disease is caused by mutations affecting the gene represented in this entry.<ref>PMID:1928092</ref> <ref>PMID:16941474</ref> <ref>PMID:16538002</ref> <ref>PMID:19472408</ref> <ref>PMID:11511921</ref> <ref>PMID:7586649</ref> <ref>PMID:12393180</ref>  

[https://www.uniprot.org/uniprot/BGAL_HUMAN BGAL_HUMAN] Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.<ref>PMID:8922281</ref>  Isoform 2 has no beta-galactosidase catalytic activity, but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP), a major component of the non-integrin cell surface receptor expressed on fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. In elastin producing cells, associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers.<ref>PMID:8922281</ref>  

[[Category: Homo sapiens]]

[[Category: Ohto U]]

[[Category: Shimizu T]]

[[Category: Suzuki H]]